To further strengthen our hypothesis that activation of the PPARα pathway by endogenous ligands leads to cancer cell proliferation and becomes dependent on this pathway, we compared the ability of PHA665752 and NSC3852 to kill cancer cells with different expression levels of PPARα. This evidence concerns the gene PPARA and cancer.